Influenza: The role of burden-of-illness research

PharmacoEconomics

Volumn 16, Issue SUPPL. 1, 1999, Pages 27-32

  Szucs, Thomas D ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; CONFERENCE PAPER; COST OF ILLNESS; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INFLUENZA; PREVALENCE; PRIORITY JOURNAL;

COST OF ILLNESS; FRANCE; HEALTH CARE COSTS; HUMANS; INFLUENZA, HUMAN; RESEARCH; SEVERITY OF ILLNESS INDEX;

EID: 0032741319     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199916001-00004     Document Type: Conference Paper

References (21)

1. Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974-1976. N Engl J Med 1978; 298: 587-92
2. Glezen WP, Payne AA, Snyder DN, et al. Mortality and influenza. J Infect Dis 1982; 146: 313-21
3. Office of Technology Assessment. Washington, 1984
4. Statistical Yearbook for Germany. Frankfurt, 1997 )
5. Levy E. French economic evaluations of influenza and influenza vaccination. Pharmacoeconomics 1996; 9 Suppl. 3:62-6
6. Sullivan KM. Health impact of influenza in the United States. Pharmacoeconomics 1996; 9 Suppl. 3: 26-33
7. Taber LH, Paredes A, Glezen WP, et al. Infection with influenza A/Victoria virus in Houston families, 1976. J Hyg (Lond) 1981; 86: 303-13
8. Perrolta DM, Decker M, Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985; 122: 468-76
9. Cate TR. Clinical manifestations and consequences of influenza. Am J Med 1987; 82 Suppl. 6A: 15-9
10. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87 (12): 1944-50
11. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77 (6): 712-5
12. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982; 142: 85-9
13. Smith A. The socioeconomic aspects and behavioural effects of influenza. In: Wood C, editor. Influenza: strategies for prevention. London: Royal Society of Medicine, 1988: 46-52
14. Schoenbaum SC. Impact of influenza in persons and populations. In: Brown LE, Hampson AW, Webster RG, editors. Options for the control of influenza, III. New York: Elsevier Science BV, 1996: 17-25
15. Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 1977; 67: 1063-70
16. Treanor JJ. New approaches to influenza vaccine high doses, neuraminidase vaccines, alternative substrates, and new adjuvants. Infect Med 1998; 15: 487-92
17. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Inf 1993; 110: 145-60
18. Smith AP, Thomas M, Brockman P, et al. Effect of influenza virus B infection on human performance. BMJ 1993; 306: 760-1
19. Smith AP. Colds, flu and performance. Occup Health Rev 1995; Nov/Dec: 29-33
20. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998; 158: 645-50
21. Johanneson M, Jonsson B. Economic evaluation in health care: is there a role for cost benefit analysis? Health Policy 1991; 17: 1-23